Nodular basal cell carcinoma of the face successfully treated with ingenol mebutate 0.015% gel
Surgical excision is the first-choice treatment for basal cell carcinoma (BCC). Other treatments with topical agents such as 5-fluoruracil or imiquimod have also been suggested for use in superficial BCC (sBCC). Ingenol mebutate (IM) is a novel agent employed in the treatment of superficial actinic...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Mattioli1885
2018-04-01
|
| Series: | Dermatology Practical & Conceptual |
| Subjects: | |
| Online Access: | http://dpcj.org/index.php/dpc/article/view/411 |